Ledger.Open graph →
SEC Form D · filed May 20, 2024

Immix Biopharma, Inc

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Gabriel Morris · LOS ANGELES, CAExec · DirectorIlya Rachman · LOS ANGELES, CAExec · DirectorJason Hsu · LOS ANGELES, CADirectorCarey Ng · La Jolla, CADirectorMagda Marquet · San Diego, CADirectorYekaterina Chudnovsky · Boston, MADirectorJane Buchan · LOS ANGELES, CADirectorHelen C. Adams · LOS ANGELES, CADirectorMagda Marquet · San Diego, CADirectorCarey Ng · La Jolla, CADirectorMagda Marquet · LOS ANGELES, CADirectorJane Buchan · LOS ANGELES, CADirectorHelen C. Adams · LOS ANGELES, CADirectorGabriel Morris · LOS ANGELES, CAExec · DirectorIlya Rachman · LOS ANGELES, CAExec · DirectorJason Hsu · LOS ANGELES, CADirectorYekaterina Chudnovsky · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗